Table of Contents
| << Previous Issue | Feb 2011 (Vol: 2011, Issue: 2) | Next Issue >> |
- Section: Cartoons
-
Once-a-week
- Section: Distribution & Marketing
-
Allergan and MAP Pharmaceuticals Sign Co-Promotion Deal for Acute Migraine Treatment
- Section: Licensing
-
Astellas Licenses Regional Rights to Optimer Pharmaceuticals’ Antibiotic for Clostridium Difficile Infection
-
Progenics Licenses Relistor® to Salix Outside of Japan
- Section: Mergers & Acquisitions
-
Novartis Advances its Capabilities in Personalised Medicine with Genoptix Acquisition
-
Amgen Signs Billion-Dollar Deal to Acquire BioVex for its Oncolytic Vaccine
-
Alexion Pharmaceuticals Boosts its Rare Disease Pipeline with Taligen Acquisition
-
Valeant to Acquire PharmaSwiss and Expand its Presence in Central and Eastern Europe
-
AdventRx Acquires SynthRx for Late-Stage Sickle Cell Disease Drug
- Section: Opinion & Analysis
-
ANNUAL REVIEW: Deal Making in 2010
- Section: Research & Development
-
Anacor and Medicis in US$160 M Acne Research Pact
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS